RBC Capital analyst Sean Dodge maintained a Buy rating on Healthequity (HQY - Research Report) on September 6 and set a price target of $70.00. The company's shares closed yesterday at $64.08.Dodge covers the Technology sector, focusing on stocks such as Signify Health, GoodRx Holdings, and Thorne HealthTech. According to TipRanks, Dodge has an average return of -2.8% and a 44.11% success rate on recommended stocks. In addition to RBC Capital, Healthequity also received a Buy from Deutsche Bank's George Hill in a report issued yesterday. However, on the same day, Goldman Sachs maintained a Sell rating on Healthequity (NASDAQ: HQY).
https://www.tipranks.com/news/blurbs/healthequity-hqy-gets-a-buy-from-rbc-capital?utm_source=advfn.com&utm_medium=referral